高级检索
杨娟, 张杭杰, 廖雨婷, 周梦天, 蒋健敏, 苏迎盈, 吕华坤. 新冠病毒疫苗临床研究与真实世界研究使用进展[J]. 中国公共卫生, 2021, 37(9): 1433-1437. DOI: 10.11847/zgggws1135895
引用本文: 杨娟, 张杭杰, 廖雨婷, 周梦天, 蒋健敏, 苏迎盈, 吕华坤. 新冠病毒疫苗临床研究与真实世界研究使用进展[J]. 中国公共卫生, 2021, 37(9): 1433-1437. DOI: 10.11847/zgggws1135895
YANG Juan, ZHANG Hang-jie, LIAO Yu-ting, . Development of COVID-19 vaccine in clinical trials and real word using[J]. Chinese Journal of Public Health, 2021, 37(9): 1433-1437. DOI: 10.11847/zgggws1135895
Citation: YANG Juan, ZHANG Hang-jie, LIAO Yu-ting, . Development of COVID-19 vaccine in clinical trials and real word using[J]. Chinese Journal of Public Health, 2021, 37(9): 1433-1437. DOI: 10.11847/zgggws1135895

新冠病毒疫苗临床研究与真实世界研究使用进展

Development of COVID-19 vaccine in clinical trials and real word using

  • 摘要: 新冠病毒疫苗接种对新冠疫情防控具有重要意义,目前已有多种类型包括mRNA、重组蛋白、腺病毒载体和灭活病毒疫苗在全世界范围内获批使用。临床试验和真实世界研究(RWR)结果显示候选疫苗具有较好的安全性和有效性。与此同时,疫苗对特定的亚群体,包括老年人、怀孕和哺乳妇女以及癌症、自身免疫性疾病患者的保护效果仍需进一步研究。另外,随着变异毒株在全球范围内逐渐流行,疫苗对变异毒株的有效性仍有待观察。本综述主要讨论目前公布关于新冠疫苗临床试验数据的有效性、安全性,对特殊人群的保护性,以及对不同病毒变异株的科学数据。

     

    Abstract: Inoculation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in populations is very important for the prevention and control of coronavirus disease 2019 (COVID-19) pandemic and currently many types of COVID-19 vaccines, including mRNA, recombinant protein, adenovirus vector and inactivated virus vaccine, have been approved worldwide. The results of clinical trials and real-world studies have demonstrated that the candidate vaccines are safe and effective. Meanwhile, the protective effect of the vaccines on specific subgroups, such as the elderly, pregnant or lactating women, patients with cancer or autoimmune diseases, still needs to be further studied. In addition, the effectiveness of the vaccines against the mutated strains of SARS-CoV-2 increasingly prevalent worldwide remains to be observed. The literature study reviews researches on efficacy and safety of COVID-19 vaccine, especially its protective effect in specific populations and the people infected by variant SARS-CoV-2 strains.

     

/

返回文章
返回